No. of resources: 90
Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19

Region : Global Commitment

Topics : COVID-19

Year :

Source :

Bayers Investor Annual Reports 2016

Region : Global Commitment

Year :

Source :

Shionogi Integrated Report 2016

Region : Global

Year :
Shionogi Financial Results 2016

Region : Global

Year :
Sumitomo Dainippon Annual Report 2016

Region : Global Commitment

Year :

Source :

Takeda Financial Report 2016

Region : Global

Year :
Takeda Financial Report 2014

Region : Global

Year :
Takeda Announces Bold, New Access to Medicines Strategy
UCB Annual Report 2016

Region : Global

Year :
Lifesaving cancer care: real tools for women who urgently need them

Region : Americas

Topics : Cancer

Year :

Pages